0001209191-14-049691.txt : 20140731
0001209191-14-049691.hdr.sgml : 20140731
20140731123025
ACCESSION NUMBER: 0001209191-14-049691
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140731
FILED AS OF DATE: 20140731
DATE AS OF CHANGE: 20140731
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aegerion Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001338042
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202960116
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1850
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 500-7867
MAIL ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1850
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Aegerion Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beer Marc D
CENTRAL INDEX KEY: 0001314575
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34921
FILM NUMBER: 141005457
MAIL ADDRESS:
STREET 1: C/O AEGERION PHARMACEUTICALS
STREET 2: 89 HEADQUARTERS PLAZA, SUITE 1212
CITY: MORRISTOWN
STATE: NJ
ZIP: 07960
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-07-31
0
0001338042
Aegerion Pharmaceuticals, Inc.
AEGR
0001314575
Beer Marc D
C/O AEGERION PHARMACEUTICALS, INC.
101 MAIN STREET, SUITE 1850
CAMBRIDGE
MA
02142
1
1
0
0
Chief Executive Officer
Common Stock
2014-07-31
4
P
0
7700
33.44
A
77100
D
Common Stock
2014-07-31
4
P
0
2300
34.37
A
79400
D
Common Stock
183245
I
By revocable trust
Common Stock
55861
I
By grantor retained annuity trust
Common Stock
7156
I
By Roth IRA
Common Stock
200
I
By son
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.02 to $33.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $34.02 to $34.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Anne Marie Cook, attorney-in-fact
2014-07-31